BIM
Baldwin Investment Management’s Immunome IMNM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $236K | Hold |
25,394
| – | – | 0.03% | 196 |
|
|
2025
Q1 | $171K | Hold |
25,394
| – | – | 0.02% | 199 |
|
|
2024
Q4 | $270K | Hold |
25,394
| – | – | 0.04% | 180 |
|
|
2024
Q3 | $371K | Hold |
25,394
| – | – | 0.05% | 172 |
|
|
2024
Q2 | $307K | Hold |
25,394
| – | – | 0.04% | 177 |
|
|
2024
Q1 | $627K | Hold |
25,394
| – | – | 0.09% | 136 |
|
|
2023
Q4 | $272K | Hold |
25,394
| – | – | 0.04% | 180 |
|
|
2023
Q3 | $212K | Hold |
25,394
| – | – | 0.04% | 185 |
|
|
2023
Q2 | $201K | Hold |
25,394
| – | – | 0.03% | 195 |
|
|
2023
Q1 | $127K | Hold |
25,394
| – | – | 0.02% | 198 |
|
|
2022
Q4 | $56.1K | Hold |
25,394
| – | – | 0.01% | 195 |
|
|
2022
Q3 | $113 | Hold |
25,394
| – | – | 0.02% | 197 |
|
|
2022
Q2 | $82 | Hold |
25,394
| – | – | 0.02% | 215 |
|
|
2022
Q1 | $144 | Buy |
+25,394
| New | +$144 | 0.02% | 241 |
|
|
2021
Q4 | – | Sell |
-9,196
| Closed | -$224K | – | 259 |
|
|
2021
Q3 | $224K | Buy |
+9,196
| New | +$224K | 0.04% | 231 |
|
|
2021
Q2 | – | Sell |
-25,394
| Closed | -$860K | – | 256 |
|
|
2021
Q1 | $860K | Buy |
+25,394
| New | +$860K | 0.16% | 111 |
|